查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405779

液体活检市场规模、份额、趋势分析报告：按生物标记、按应用、按技术、按样本类型、按临床应用、按最终用途、按产品、按地区、细分市场预测，2024-2030 年

Liquid Biopsy Market Size, Share & Trends Analysis Report By Biomarker, By Application, By Technology, By Sample Type, By Clinical Application, By End-use, By Product, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

液体活检市场成长和趋势：

2030年，全球液体切片市场规模为228.8亿美元，预计2023年至2030年复合年增长率为9.7%。

癌症盛行率的增加和老年人口的增加是预计推动市场成长的主要因素。此外，使用技术先进的设备进行疾病的早期检测是推动市场的关键因素之一。此外，对非侵入性治疗程序的日益偏好可能会在预测期内提供利润丰厚的机会。

近年来，受癌症影响的人数显着增加，预计这一趋势将在一段时间内保持不变。生活方式的显着改变使世界人口面临这种疾病和致癌物质的威胁。例如，根据美国癌症协会的数据，到 2022 年，预计新增癌症病例数将达到 190 万例，死亡人数将达到 609,360 人。公司正专注于扩大临床液体活检领域的业务。

例如，2021年12月，Helio Health和Fulgent Genetics宣布推出前者的HelioLiver，这是一种用于早期检测肝癌的新型液体活检测试。这种液体活检结合了血清蛋白标记物和游离 DNA 甲基化模式。此外，新的研究和开发正在帮助开发新的液体活检技术。例如，2022 年 7 月，中佛罗里达大学宣布开发出一种新型液体活检技术，透过识别生物标记和促进病理监测来促进肺癌和乳癌的早期检测。

公司对液体活检的兴趣日益浓厚，新产品的核准率不断提高，进一步加速了市场的成长。此外，近年来，研究显示液体活检平台取得了积极的成果。各国政府和各个监管机构也对此领域表现出了兴趣，透过推广多种突破性设备来促进该技术的快速发展。由于各公司对该技术的采用率很高，以及政府资金和倡议的支持，预计该市场在未来几年将会成长。

液体活检市场报告亮点

  • 由于 ctDNA 广泛用作液体活检癌症检测中的生物标记物，因此预计将占据最大的市场份额。
  • 由于研究和开发的增加、癌症患者数量的增加、技术的进步以及大公司的策略活动，多基因并行分析（NGS）技术领域预计将出现高速成长。
  • 由于该地区对新技术的需求不断增长、拥有大量主要企业、拥有多个临床实验室以及先进的医疗基础设施，北美将在 2022 年主导全球市场。
  • 由于目标疾病盛行率上升以及该地区主要企业的存在，预计亚太地区未来将显着增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 市场驱动因素
    • 癌症发生率增加
    • 老年人口增加
    • 技术进步
    • 对非侵入性治疗的兴趣日益浓厚
  • 市场抑制因素分析
    • 一种重磅处方药的专利到期
  • 营商环境分析
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第 4 章 类型业务分析

  • 液体切片市场：类型变异分析
  • 血液样本
    • 血液样本市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第五章生物标记业务分析

  • 液体切片市场：生物标记波动分析
  • 循环性肿瘤细胞(CTC)
    • 循环性肿瘤细胞
  • 循环肿瘤 DNA (Catena)
    • 循环核酸市场，2018-2030
  • 胞外体/微囊泡
    • 胞外体/微囊泡市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第六章技术业务分析

  • 液体切片市场：技术变化分析
  • 多基因平行分析（NGS）
    • 多个基因的平行分析
  • 单基因分析（PCR 微阵列）
    • 单基因分析

第七章 应用业务分析

  • 液体切片市场：应用变化分析
  • 癌症
    • 癌症市场，2018-2030
  • 生殖健康
    • 生殖健康市场，2018-2030
  • 其他的
    • 其他市场，2018-2030

第 8 章最终用途业务分析

  • 液体活检市场：最终用途变化分析
  • 医院/研究所
    • 2018-2030年医院及研究所市场
  • 专科诊所
    • 2018-2030年专科诊所市场
  • 学术研究中心
    • 学术研究中心市场，2018-2030
  • 其他的
    • 其他液体活检市场，2018-2030

第九章临床应用业务分析

  • 液体切片市场：临床应用波动分析
  • 治疗方法选择
    • 治疗方法选择市场，2018-2030
  • 治疗监测
    • 治疗监测市场，2018-2030
  • 早期癌症筛检
    • 早期癌症筛检市场，2018-2030
  • 监测復发情况
    • 復发监测市场，2018-2030
  • 其他的
    • 其他液体活检市场，2018-2030

第10章产品业务分析

  • 液体切片市场：产品变异分析
  • 装置
    • 2018-2030年设备市场
  • 耗材套件和试剂
    • 耗材套件与试剂市场，2018-2030
  • 软体服务
    • 软体与服务市场，2018-2030

第十一章区域业务分析

  • 2023 年和 2030 年液体活检市场占有率（按地区）
  • 北美洲
    • 北美液体活检市场，2018-2030
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲液体活检市场，2018-2030
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 亚太液体活检市场，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 拉丁美洲液体活检市场，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 中东和非洲液体活检市场，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第十二章竞争形势

  • 参与企业概况
  • 财务绩效
  • 参与企业
    • 市场领导者
    • 2023 年液体切片市场占有率分析
    • 公司简介
    • 策略规划
Product Code: GVR-1-68038-105-4

Liquid Biopsy Market Growth & Trends:

The global Liquid Biopsy Market size was valued at USD 22.88 billion in 2030 and is expected to expand at a compound annual growth rate (CAGR) of 9.7% from 2023 to 2030. The increasing prevalence of cancer and the growing geriatric population are major drivers expected to fuel market growth. Furthermore, the use of technologically advanced devices for early detection of diseases is one of the key factors driving the market. In addition, the increasing preference for noninvasive treatment procedures will offer lucrative opportunities in the forecast period.

In recent years, cases of cancer have been rising tremendously and the trend is projected to remain the same in the foreseeable future. A significant shift in lifestyle has exposed the global population to this disorder and has resulted in oncogenic factors. For instance, as per the American Cancer Society, in 2022, the number of new cancer cases is expected to reach 1.9 million, leading to 609,360 deaths. Companies are focusing on expanding their business operations in the clinical liquid biopsy space.

For instance, in December 2021, Helio Health and Fulgent Genetics announced the launch of the former's HelioLiver, a new liquid biopsy test for early liver cancer detection. This liquid biopsy test combines serum protein markers and cell-free DNA methylation patterns. Additionally, new research studies are aiding the development of novel liquid biopsy techniques. For instance, in July 2022, the University of Central Florida announced the development of a novel liquid biopsy technique that facilitates early detection using biomarker identification for lung and breast cancer, making the monitoring of conditions easier.

The enhanced interest of players in liquid biopsy and the increasing rate of approval of new products are further accelerating market growth. Moreover, in the past several years, studies have shown a positive outcome of liquid biopsy platforms. Governments and various regulatory bodies have also shown interest in the area by promoting multiple breakthrough devices for the rapid development of this technology. With the high adoption of the technology by various companies, along with the support of government funding and initiatives, the market is expected to grow in the coming years.

Liquid Biopsy Market Report Highlights:

  • The ctDNA segment is projected to hold the largest share in the market owing to its wide use as a biomarker in the detection of cancer using liquid biopsy
  • The multi-gene-parallel analysis (NGS) technology segment is expected to grow lucratively due to increasing research and development, increasing cancer cases, advancements in technology, and strategic activities by leading companies
  • North America dominated the global market in 2022, owing to the increasing demand for new technologies, a large pool of key players, the presence of several clinical laboratories, and advanced healthcare infrastructure in the region
  • Asia Pacific is expected to grow considerably in the future, owing to the rising prevalence of target conditions in the region and the presence of key players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers
    • 3.4.1. Increasing prevalence of cancer
    • 3.4.2. Growing geriatric population
    • 3.4.3. Technological advancements
    • 3.4.4. Increasing preference for noninvasive treatment
  • 3.5. Market Restraint Analysis
    • 3.5.1. Patent expiry of blockbuster drugs prescribed
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Liquid Biopsy Market: Type Movement Analysis
  • 4.2. Blood Sample
    • 4.2.1. Blood Sample Market, 2018 - 2030 (USD Million)
  • 4.3. Others
    • 4.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Biomarker Business Analysis

  • 5.1. Liquid Biopsy Market: Biomarker Movement Analysis
  • 5.2. Circulating Tumor Cells (CTCs)
    • 5.2.1. Circulating Tumor Cells (CTCs) Market, 2018 - 2030 (USD Million)
  • 5.3. Circulating Tumor DNA (catena)
    • 5.3.1. Circulating Nucleic Acids Market, 2018 - 2030 (USD Million)
  • 5.4. Exosomes/Microvesicles
    • 5.4.1. Exosomes/Microvesicles Market, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Technology Business Analysis

  • 6.1. Liquid Biopsy Market: Technology Movement Analysis
  • 6.2. Multi-gene-parallel Analysis (NGS)
    • 6.2.1. Multi-gene-parallel Analysis (NGS) Market, 2018 - 2030 (USD Million)
  • 6.3. Single Gene Analysis (PCR Microarrays)
    • 6.3.1. Single Gene Analysis (PCR Microarrays) Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. Liquid Biopsy Market: Application Movement Analysis
  • 7.2. Cancer
    • 7.2.1. Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.1. Lung Cancer
      • 7.2.1.2. Lung Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.3. Prostate Cancer
      • 7.2.1.4. Prostate Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.5. Breast Cancer
      • 7.2.1.6. Breast Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.7. Colorectal Cancer
      • 7.2.1.8. Colorectal Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.9. Leukemia
      • 7.2.1.10. Leukemia Market, 2018 - 2030 (USD Million)
      • 7.2.1.11. Gastrointestinal Cancer
      • 7.2.1.12. Gastrointestinal Cancer Market, 2018 - 2030 (USD Million)
      • 7.2.1.13. Others
      • 7.2.1.14. Others Market, 2018 - 2030 (USD Million)
  • 7.3. Reproductive Health
    • 7.3.1. Reproductive Health Market, 2018 - 2030 (USD Million)
  • 7.4. Others
    • 7.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-Use Business Analysis

  • 8.1. Liquid Biopsy Market: End-Use Movement Analysis
  • 8.2. Hospitals and Laboratories
    • 8.2.1. Hospitals and Laboratories Market, 2018 - 2030 (USD Million)
  • 8.3. Specialty Clinics
    • 8.3.1. Specialty Clinics Market, 2018 - 2030 (USD Million)
  • 8.4. Academic and Research Centers
    • 8.4.1. Academic and Research Centers Market, 2018 - 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Others Liquid Biopsy Market, 2018 - 2030 (USD Million)

Chapter 9. Clinical Application Business Analysis

  • 9.1. Liquid Biopsy Market: Clinical Application Movement Analysis
  • 9.2. Therapy Selection
    • 9.2.1. Therapy Selection Market, 2018 - 2030 (USD Million)
  • 9.3. Treatment Monitoring
    • 9.3.1. Treatment Monitoring Market, 2018 - 2030 (USD Million)
  • 9.4. Early Cancer Screening
    • 9.4.1. Early Cancer Screening Market, 2018 - 2030 (USD Million)
  • 9.5. Recurrence Monitoring
    • 9.5.1. Recurrence Monitoring Market, 2018 - 2030 (USD Million)
  • 9.6. Others
    • 9.6.1. Others Liquid Biopsy Market, 2018 - 2030 (USD Million)

Chapter 10. Product Business Analysis

  • 10.1. Liquid Biopsy Market: Product Movement Analysis
  • 10.2. Instruments
    • 10.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 10.3. Consumables Kits and Reagents
    • 10.3.1. Consumables Kits and Reagents Market, 2018 - 2030 (USD Million)
  • 10.4. Software and Services
    • 10.4.1. Software and Services Market, 2018 - 2030 (USD Million)

Chapter 11. Regional Business Analysis

  • 11.1. Liquid Biopsy Market Share By Region, 2023 & 2030
  • 11.2. North America
    • 11.2.1. North America Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.2.2. U.S.
      • 11.2.2.1. Key Country Dynamics
      • 11.2.2.2. Target Disease Prevalence
      • 11.2.2.3. Competitive Scenario
      • 11.2.2.4. Regulatory Framework
      • 11.2.2.5. Reimbursement Scenario
      • 11.2.2.6. U.S. Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.2.3. Canada
      • 11.2.3.1. Key Country Dynamics
      • 11.2.3.2. Target Disease Prevalence
      • 11.2.3.3. Competitive Scenario
      • 11.2.3.4. Regulatory Framework
      • 11.2.3.5. Reimbursement Scenario
      • 11.2.3.6. Canada Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.3. Europe
    • 11.3.1. Europe Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.2. Germany
      • 11.3.2.1. Key Country Dynamics
      • 11.3.2.2. Target Disease Prevalence
      • 11.3.2.3. Competitive Scenario
      • 11.3.2.4. Regulatory Framework
      • 11.3.2.5. Reimbursement Scenario
      • 11.3.2.6. Germany Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.3. UK
      • 11.3.3.1. Key Country Dynamics
      • 11.3.3.2. Target Disease Prevalence
      • 11.3.3.3. Competitive Scenario
      • 11.3.3.4. Regulatory Framework
      • 11.3.3.5. Reimbursement Scenario
      • 11.3.3.6. UK Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.4. France
      • 11.3.4.1. Key Country Dynamics
      • 11.3.4.2. Target Disease Prevalence
      • 11.3.4.3. Competitive Scenario
      • 11.3.4.4. Regulatory Framework
      • 11.3.4.5. Reimbursement Scenario
      • 11.3.4.6. France Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.5. Italy
      • 11.3.5.1. Key Country Dynamics
      • 11.3.5.2. Target Disease Prevalence
      • 11.3.5.3. Competitive Scenario
      • 11.3.5.4. Regulatory Framework
      • 11.3.5.5. Reimbursement Scenario
      • 11.3.5.6. Italy Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.6. Spain
      • 11.3.6.1. Key Country Dynamics
      • 11.3.6.2. Target Disease Prevalence
      • 11.3.6.3. Competitive Scenario
      • 11.3.6.4. Regulatory Framework
      • 11.3.6.5. Reimbursement Scenario
      • 11.3.6.6. Spain Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.7. Denmark
      • 11.3.7.1. Key Country Dynamics
      • 11.3.7.2. Target Disease Prevalence
      • 11.3.7.3. Competitive Scenario
      • 11.3.7.4. Regulatory Framework
      • 11.3.7.5. Reimbursement Scenario
      • 11.3.7.6. Denmark Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.8. Sweden
      • 11.3.8.1. Key Country Dynamics
      • 11.3.8.2. Target Disease Prevalence
      • 11.3.8.3. Competitive Scenario
      • 11.3.8.4. Regulatory Framework
      • 11.3.8.5. Reimbursement Scenario
      • 11.3.8.6. Sweden Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.3.9. Norway
      • 11.3.9.1. Key Country Dynamics
      • 11.3.9.2. Target Disease Prevalence
      • 11.3.9.3. Competitive Scenario
      • 11.3.9.4. Regulatory Framework
      • 11.3.9.5. Reimbursement Scenario
      • 11.3.9.6. Norway Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.4. Asia Pacific
    • 11.4.1. Asia Pacific Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.2. Japan
      • 11.4.2.1. Key Country Dynamics
      • 11.4.2.2. Target Disease Prevalence
      • 11.4.2.3. Competitive Scenario
      • 11.4.2.4. Regulatory Framework
      • 11.4.2.5. Reimbursement Scenario
      • 11.4.2.6. Japan Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.3. China
      • 11.4.3.1. Key Country Dynamics
      • 11.4.3.2. Target Disease Prevalence
      • 11.4.3.3. Competitive Scenario
      • 11.4.3.4. Regulatory Framework
      • 11.4.3.5. Reimbursement Scenario
      • 11.4.3.6. China Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.4. India
      • 11.4.4.1. Key Country Dynamics
      • 11.4.4.2. Target Disease Prevalence
      • 11.4.4.3. Competitive Scenario
      • 11.4.4.4. Regulatory Framework
      • 11.4.4.5. Reimbursement Scenario
      • 11.4.4.6. India Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.5. South Korea
      • 11.4.5.1. Key Country Dynamics
      • 11.4.5.2. Target Disease Prevalence
      • 11.4.5.3. Competitive Scenario
      • 11.4.5.4. Regulatory Framework
      • 11.4.5.5. Reimbursement Scenario
      • 11.4.5.6. South Korea Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.6. Australia
      • 11.4.6.1. Key Country Dynamics
      • 11.4.6.2. Target Disease Prevalence
      • 11.4.6.3. Competitive Scenario
      • 11.4.6.4. Regulatory Framework
      • 11.4.6.5. Reimbursement Scenario
      • 11.4.6.6. Australia Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.4.7. Thailand
      • 11.4.7.1. Key Country Dynamics
      • 11.4.7.2. Target Disease Prevalence
      • 11.4.7.3. Competitive Scenario
      • 11.4.7.4. Regulatory Framework
      • 11.4.7.5. Reimbursement Scenario
      • 11.4.7.6. Thailand Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.5. Latin America
    • 11.5.1. Latin America Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.2. Brazil
      • 11.5.2.1. Key Country Dynamics
      • 11.5.2.2. Target Disease Prevalence
      • 11.5.2.3. Competitive Scenario
      • 11.5.2.4. Regulatory Framework
      • 11.5.2.5. Reimbursement Scenario
      • 11.5.2.6. Brazil Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.3. Mexico
      • 11.5.3.1. Key Country Dynamics
      • 11.5.3.2. Target Disease Prevalence
      • 11.5.3.3. Competitive Scenario
      • 11.5.3.4. Regulatory Framework
      • 11.5.3.5. Reimbursement Scenario
      • 11.5.3.6. Mexico Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.5.4. Argentina
      • 11.5.4.1. Key Country Dynamics
      • 11.5.4.2. Target Disease Prevalence
      • 11.5.4.3. Competitive Scenario
      • 11.5.4.4. Regulatory Framework
      • 11.5.4.5. Reimbursement Scenario
      • 11.5.4.6. Argentina Liquid biopsy market, 2018 - 2030 (USD Million)
  • 11.6. MEA
    • 11.6.1. MEA Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.2. South Africa
      • 11.6.2.1. Key Country Dynamics
      • 11.6.2.2. Target Disease Prevalence
      • 11.6.2.3. Competitive Scenario
      • 11.6.2.4. Regulatory Framework
      • 11.6.2.5. Reimbursement Scenario
      • 11.6.2.6. South Africa Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.3. Saudi Arabia
      • 11.6.3.1. Key Country Dynamics
      • 11.6.3.2. Target Disease Prevalence
      • 11.6.3.3. Competitive Scenario
      • 11.6.3.4. Regulatory Framework
      • 11.6.3.5. Reimbursement Scenario
      • 11.6.3.6. Saudi Arabia Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.4. UAE
      • 11.6.4.1. Key Country Dynamics
      • 11.6.4.2. Target Disease Prevalence
      • 11.6.4.3. Competitive Scenario
      • 11.6.4.4. Regulatory Framework
      • 11.6.4.5. Reimbursement Scenario
      • 11.6.4.6. UAE Liquid biopsy market, 2018 - 2030 (USD Million)
    • 11.6.5. Kuwait
      • 11.6.5.1. Key Country Dynamics
      • 11.6.5.2. Target Disease Prevalence
      • 11.6.5.3. Competitive Scenario
      • 11.6.5.4. Regulatory Framework
      • 11.6.5.5. Reimbursement Scenario
      • 11.6.5.6. Kuwait Liquid biopsy market, 2018 - 2030 (USD Million)

Chapter 12. Competitive Landscape

  • 12.1. Participant's overview
  • 12.2. Financial performance
  • 12.3. Participant categorization
    • 12.3.1. Market Leaders
    • 12.3.2. Liquid Biopsy Market Share Analysis, 2023
    • 12.3.3. Company Profiles
      • 12.3.3.1. ANGLE plc
      • 12.3.3.1.1. Company Overview
      • 12.3.3.1.2. Financial Performance
      • 12.3.3.1.3. Product Benchmarking
      • 12.3.3.1.4. Strategic Initiatives
      • 12.3.3.2. Oncimmune Holdings PLC
      • 12.3.3.2.1. Company Overview
      • 12.3.3.2.2. Financial Performance
      • 12.3.3.2.3. Product Benchmarking
      • 12.3.3.2.4. Strategic Initiatives
      • 12.3.3.3. Guardant Health
      • 12.3.3.3.1. Company Overview
      • 12.3.3.3.2. Financial Performance
      • 12.3.3.3.3. Product Benchmarking
      • 12.3.3.3.4. Strategic Initiatives
      • 12.3.3.4. Myriad Genetics, Inc.
      • 12.3.3.4.1. Company Overview
      • 12.3.3.4.2. Financial Performance
      • 12.3.3.4.3. Product Benchmarking
      • 12.3.3.4.4. Strategic Initiatives
      • 12.3.3.5. Biocept, Inc.
      • 12.3.3.5.1. Company Overview
      • 12.3.3.5.2. Financial Performance
      • 12.3.3.5.3. Product Benchmarking
      • 12.3.3.5.4. Strategic Initiatives
      • 12.3.3.6. Lucence Health Inc.
      • 12.3.3.6.1. Company Overview
      • 12.3.3.6.2. Financial Performance
      • 12.3.3.6.3. Product Benchmarking
      • 12.3.3.6.4. Strategic Initiatives
      • 12.3.3.7. Freenome Holdings, Inc.
      • 12.3.3.7.1. Company Overview
      • 12.3.3.7.2. Financial Performance
      • 12.3.3.7.3. Product Benchmarking
      • 12.3.3.7.4. Strategic Initiatives
      • 12.3.3.8. F. Hoffmann-La Roche Ltd.
      • 12.3.3.8.1. Company Overview
      • 12.3.3.8.2. Financial Performance
      • 12.3.3.8.3. Product Benchmarking
      • 12.3.3.8.4. Strategic Initiatives
      • 12.3.3.9. QIAGEN
      • 12.3.3.9.1. Company Overview
      • 12.3.3.9.2. Financial Performance
      • 12.3.3.9.3. Product Benchmarking
      • 12.3.3.9.4. Strategic Initiatives
      • 12.3.3.10. Illumina, Inc.
      • 12.3.3.10.1. Company Overview
      • 12.3.3.10.2. Financial Performance
      • 12.3.3.10.3. Product Benchmarking
      • 12.3.3.10.4. Strategic Initiatives
      • 12.3.3.11. Thermo Fisher Scientific, Inc.
      • 12.3.3.11.1. Company Overview
      • 12.3.3.11.2. Financial Performance
      • 12.3.3.11.3. Product Benchmarking
      • 12.3.3.11.4. Strategic Initiatives
      • 12.3.3.12. Epigenomics AG
      • 12.3.3.12.1. Company Overview
      • 12.3.3.12.2. Financial Performance
      • 12.3.3.12.3. Product Benchmarking
      • 12.3.3.12.4. Strategic Initiatives
    • 12.3.4. Strategy Mapping
      • 12.3.4.1. Expansion
      • 12.3.4.2. Acquisition
      • 12.3.4.3. Collaborations
      • 12.3.4.4. Disease Type/Drug Class Launch
      • 12.3.4.5. Partnerships
      • 12.3.4.6. Others

List of Tables

  • Table 1 List of Tables
  • Table 2 Global Liquid Biopsy Market, By Region, 2018 - 2030 (USD Million)
  • Table 3 Global Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 4 Global Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 5 Global Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 7 Global Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 8 Global Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 9 Global Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 10 North America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 North America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 12 North America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 13 North America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 14 North America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 15 North America Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 16 North America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 17 North America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 18 U.S. Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 19 U.S. Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 20 U.S. Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 21 U.S. Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 22 U.S. Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 23 U.S. Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 24 U.S. Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Canada Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 26 Canada Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 27 Canada Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 28 Canada Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 29 Canada Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 30 Canada Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 31 Canada Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 32 Europe Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 33 Europe Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 34 Europe Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 35 Europe Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 36 Europe Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 37 Europe Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 38 Europe Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 39 Europe Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 40 UK Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 41 UK Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 42 UK Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 UK Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 44 UK Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 45 UK Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 46 UK Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 47 Germany Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 48 Germany Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 49 Germany Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 50 Germany Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 51 Germany Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 52 Germany Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 53 Germany Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 54 France Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 55 France Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 56 France Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 57 France Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 58 France Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 59 France Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 60 France Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 61 Italy Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 62 Italy Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 63 Italy Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 64 Italy Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 65 Italy Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 66 Italy Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 67 Italy Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 68 Spain Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 69 Spain Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 70 Spain Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 71 Spain Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 72 Spain Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 73 Spain Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 74 Spain Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 75 Denmark Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 76 Denmark Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 77 Denmark Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 78 Denmark Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 79 Denmark Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 80 Denmark Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 81 Denmark Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 Sweden Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 83 Sweden Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 84 Sweden Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 85 Sweden Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 86 Sweden Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 87 Sweden Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 88 Sweden Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 89 Norway Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 90 Norway Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 91 Norway Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 92 Norway Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 93 Norway Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 94 Norway Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 95 Norway Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 96 Asia Pacific Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 97 Asia Pacific Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 98 Asia Pacific Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 99 Asia Pacific Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 100 Asia Pacific Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 101 Asia Pacific Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 102 Asia Pacific Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 103 Asia Pacific Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 104 Japan Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 105 Japan Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 106 Japan Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 107 Japan Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 108 Japan Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 109 Japan Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 110 Japan Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 111 China Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 112 China Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 113 China Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 114 China Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 115 China Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 116 China Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 117 China Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 118 India Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 119 India Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 120 India Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 121 India Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 122 India Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 123 India Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 124 India Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 125 Australia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 126 Australia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 127 Australia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 128 Australia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 129 Australia Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 130 Australia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 131 Australia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 132 South Korea Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 133 South Korea Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 134 South Korea Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 135 South Korea Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 136 South Korea Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 137 South Korea Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 138 South Korea Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 139 Thailand Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 140 Thailand Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 141 Thailand Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 142 Thailand Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 143 Thailand Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 144 Thailand Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 145 Thailand Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 146 Latin America Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 147 Latin America Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 148 Latin America Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 149 Latin America Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 150 Latin America Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 151 Latin America Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 152 Latin America Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 153 Latin America Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 154 Brazil Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 155 Brazil Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 156 Brazil Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 157 Brazil Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 158 Brazil Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 159 Brazil Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 160 Brazil Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 161 Mexico Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 162 Mexico Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 163 Mexico Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 164 Mexico Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 165 Mexico Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 166 Mexico Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 167 Mexico Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 168 Argentina Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 169 Argentina Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 170 Argentina Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 171 Argentina Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 172 Argentina Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 173 Argentina Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 174 Argentina Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 175 Middle East & Africa Liquid Biopsy Market, By Country, 2018 - 2030 (USD Million)
  • Table 176 Middle East & Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 177 Middle East & Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 178 Middle East & Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 179 Middle East & Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 180 Middle East & Africa Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 181 Middle East & Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 182 Middle East & Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 183 South Africa Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 184 South Africa Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 185 South Africa Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 186 South Africa Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 187 South Africa Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 188 South Africa Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 189 South Africa Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 190 Saudi Arabia Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 191 Saudi Arabia Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 192 Saudi Arabia Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 193 Saudi Arabia Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 194 Saudi Arabia Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 195 Saudi Arabia Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 196 Saudi Arabia Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 197 UAE Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 198 UAE Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 199 UAE Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 200 UAE Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 201 UAE Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 202 UAE Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 203 UAE Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)
  • Table 204 Kuwait Liquid Biopsy Market, By Sample Type, 2018 - 2030 (USD Million)
  • Table 205 Kuwait Liquid Biopsy Market, By Biomarker, 2018 - 2030 (USD Million)
  • Table 206 Kuwait Liquid Biopsy Market, By Technology, 2018 - 2030 (USD Million)
  • Table 207 Kuwait Liquid Biopsy Market, By Application, 2018 - 2030 (USD Million)
  • Table 208 Kuwait Liquid Biopsy Market, By End-use, 2018 - 2030 (USD Million)
  • Table 209 Kuwait Liquid Biopsy Market, By Clinical Application, 2018 - 2030 (USD Million)
  • Table 210 Kuwait Liquid Biopsy Market, By Product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Liquid biopsy market segmentation
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 Market challenge relevance analysis (Current & future impact)
  • Fig. 11 Penetration & growth prospect mapping
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration vs growth prospect mapping
  • Fig. 15 Liquid biopsy market: Sample Type movement analysis
  • Fig. 16 Blood sample liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 17 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 18 Liquid biopsy market: Biomarker movement analysis
  • Fig. 19 Circulating Tumor Cells (CTCs) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 20 Circulating Nucleic Acids liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 21 Exosomes/Microvesicles liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 22 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 23 Liquid biopsy market: Technology movement analysis
  • Fig. 24 Multi-gene-parallel analysis (NGS) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 25 Single gene analysis (PCR Microarrays) liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 26 Liquid biopsy market: Application movement analysis
  • Fig. 27 Cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 28 Lung cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 29 Prostate cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 30 Breast cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 31 Colorectal cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 32 Leukemia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 33 Gastrointestinal cancer liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 34 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 35 Reproductive Health liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 36 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 37 Liquid biopsy market: End-use movement analysis
  • Fig. 38 Hospitals and Laboratories liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 39 Specialty clinics liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 40 Academic and research centers liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 41 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 42 Liquid biopsy market: Clinical application movement analysis
  • Fig. 43 Therapy selection liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 44 Treatment monitoring liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 45 Early cancer screening liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 46 Recurrence monitoring liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 47 Others liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 48 Liquid biopsy market: Product movement analysis
  • Fig. 49 Instruments liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 50 Consumables kits and reagents liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 51 Software and Services liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 52 Regional marketplace: Key takeaways
  • Fig. 53 Regional outlook, 2018 & 2030
  • Fig. 54 North America liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 55 U.S. liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 56 Canada liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 57 Europe liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 58 UK liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 59 Germany liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 60 Italy liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 61 Spain liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 62 France liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 63 Denmark liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 64 Sweden liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 65 Norway liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 67 Japan liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 68 China liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 69 India liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 70 Australia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 71 South Korea liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 73 Latin America liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 74 Brazil liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 75 Mexico liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 76 Argentina liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 77 MEA liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 78 South Africa liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 79 Saudi Arabia liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 80 UAE liquid biopsy market, 2018 - 2030 (USD Million)
  • Fig. 81 Kuwait liquid biopsy market, 2018 - 2030 (USD Million)